Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201301006 Principal Investigator: Roth, Bruce
Title: An International Phase 3, Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
Phase: III Disease Site: Kidney
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to see if treatment with AGS-003 (a drug made using a piece of a patient's tumor and a patient's own white blood cells) plus regular medications is any different than treatment with regular medications alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)